
Most patients with Duchenne muscular dystrophy require full-time use of a wheelchair by their early teens

Drug approved for patients with exon 53 mutation

Pens another gene therapy deal following takeover of Spark Therapeutics

Another blow for Sarepta following FDA rejection earlier this year

FDA gave no warnings of concerns, says chief exec

Study participant fell seriously ill

Company to press ahead with phase 3 trial

Funding will drive preclinical studies on dystrophin-bearing exosomes

News from pharma, biotech and healthcare